跳至主要内容
临床试验/RBR-8wtq2b
RBR-8wtq2b进行中(未招募)未知

Impact of macrolides in mortality of patients infected by HIV with pneumonia: a randomized clinical trial

Instituto de Infectologia Emílio Ribas0 个研究点开始时间: 2015年8月28日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 —(—)

入选标准

  • Age over 18 years; HIV infection and community acquired pneumonia.
  • Calculated sample: 228.

排除标准

  • Patients with hospitalization for two or more days in the 90 days prior to admission; coming from nursing homes or shelters; if they had health care in those sites; patients that had received intravenous antibiotics; chemotherapy or treatment of bedsores in the last 30 days; in dialysis; with another cause that justifies the lung symptoms on admission; such as pulmonary fibrosis; pneumocystosis; tuberculosis or other non-bacterial disease; pregnant or nursing women; patients allergic to the study medications (ceftriaxone and azithromycin) or patients that had already been randomized in this study.

研究者

发起方
Instituto de Infectologia Emílio Ribas

相似试验